Search Results
May 14, 2026, 08:00 ET Origin Agritech to Hold Business Update & First Half Fiscal Year 2026 Earnings Conference Call on May 22 at 8 a.m. ET
be available for two weeks.About Origin Agritech LimitedOrigin Agritech Limited, founded in 1997 and headquartered in Origin R&D Center, Songzhuang, Tongzhou in Beijing, is a leading Chinese agricultural technology company. In crop seed biotechnologies, Origin Agritech's phytase
More news about: Origin Agritech Limited
May 14, 2026, 08:00 ET Illinois CancerCare, P.C. Partners with Canopy to Expand Patient Access and Care Between Visits
Society of Hematology (ASH) Annual Meeting.3 Parrinello, C., Calkins, G., Kwiatkowsky, L., Schaefer, E. S., Beck, J. T., Ellis, A. R., Blau, S., Telivala, B. P., & Kolodziej, M. A. (2022). Time on treatment is prolonged in patients utilizing an ePRO based digital symptom monitoring
More news about: Canopy
May 14, 2026, 07:30 ET DeFi Technologies Appoints Russell Starr as Strategic Advisor
May 14, 2026 /PRNewswire/ -- DeFi Technologies Inc. (the "Company" or "DeFi Technologies") (Nasdaq: DEFT) (CBOE CA: DEFI) (GR: R9B), a financial technology company bridging the gap between traditional capital markets and decentralized finance ("DeFi"), today announced the appointment
More news about: DeFi Technologies Inc.
May 14, 2026, 07:30 ET DeFi Technologies Appoints Russell Starr as Strategic Advisor
DeFi Technologies Inc. (the "Company" or "DeFi Technologies") (Nasdaq: DEFT) (CBOE CA: DEFI) (GR: R9B), a financial technology company bridging the gap between traditional capital markets and decentralized finance ("DeFi"), today
More news about: DeFi Technologies Inc.
May 14, 2026, 07:30 ET Karyopharm Reports First Quarter 2026 Financial Results and Completion of Phase 3 Endometrial Cancer Trial Enrollment
million in royalties.Cost of sales: Cost of sales was $1.3 million for both the first quarter of 2026 and 2025.R&D expenses: R&D expenses were $33.8 million for the first quarter of 2026, compared to $34.6 million for the first quarter of 2025.SG&A expenses: SG&A
More news about: Karyopharm Therapeutics Inc.
May 14, 2026, 07:30 ET Optura Secures $17.5 Million Series A from Salesforce Ventures and Echo Health Ventures to Scale its ROAI™ Platform
health plans is no longer whether to invest in AI; it's whether those investments are actually delivering better outcomes for members," said Michael R. Vennera, Executive Vice President and Chief Strategy, Technology and Operations Officer, Independence Blue Cross. "Optura answers that question for an
More news about: Optura
May 14, 2026, 07:22 ET Changan Unveils 2030 Global Strategy, Prioritizing MEA Market as Core Overseas Hub
value, fully aligning with the MEA region's rising demand for new energy and low-carbon mobility solutions.Empowered by a 24,000-strong global R&D team and over 20,000 patents, Changan retains solid technological leadership and steady sales growth. Moving ahead, the group will deepen localized
More news about: Changan Group
May 14, 2026, 07:14 ET CGTN: jak Chiny pomagają rozwijać edukację dziewcząt i kobiet na całym świecie
szanse dla kobiet i dziewcząt na całym świecie.PEKIN, 14 maja 2026 r. /PRNewswire/ -- Od czasu wspólnego ustanowienia przez Chiny i UNESCO „Nagrody UNESCO w dziedzinie edukacji dziewcząt i kobiet" w 2015 roku, wyróżnienie
More news about: CGTN
May 14, 2026, 07:10 ET Healthcare Triangle Reports 627% Increase in Gross Profit and 166% Increase in Revenue for Q1 2026
Healthcare Triangle achieves HITRUST Certification for Cloud and Data Platform (CaDP), marketed as CloudEz™ and DataEz™. HITRUST Risk-based, 2-year (r2) Certified status demonstrates to our clients the highest standards for data protection and information security. Healthcare Triangle enables the adoption
More news about: Healthcare Triangle, Inc.
May 14, 2026, 07:10 ET REGENXBIO Reports First Quarter 2026 Financial Results and Operational Highlights
certain net sales of ITVISMA in the U.S. and other jurisdictions with patents extending until 2037.Research and Development (R&D) Expenses: R&D expenses were $57.3 million for the three months ended March 31, 2026 compared to $53.1 million for the three months ended March 31, 2025.
More news about: REGENXBIO Inc.
May 14, 2026, 07:00 ET WhiteFiber, Inc. Reports First Quarter 2026 Results
capital expenditures. The deployment is expected to begin contributing revenue in June 2026. As a reference partner, Modal Labs will support ongoing R&D through input on design and development.Balance Sheet and LiquidityCash and cash equivalents of $75.8 million
More news about: WhiteFiber, Inc.
May 14, 2026, 07:00 ET Quarterhill Reports First Quarter 2026 Financial Results
enforcement operations.Total operating expenses are comprised of selling, general, and administrative costs ("SG&A"), research and development ("R&D") costs, depreciation, amortization of intangible assets, and other charges. Total operating expenses for the quarter ended March 31, 2026, were $14.4
More news about: Quarterhill Inc.
May 14, 2026, 06:59 ET Power Monitoring Market worth $10.56 billion by 2031 | MarketsandMarkets™
healthcare, and critical infrastructure. Schneider Electric has a vast global presence, operating in over 100 countries with manufacturing facilities, R&D centers, and service networks across Europe, North America, Asia Pacific, Latin America, the Middle East, and Africa.Siemens (Germany) Siemens
More news about: MarketsandMarkets
May 14, 2026, 06:54 ET Aurora Granted Plant Breeders' Rights, Strengthening Leadership in Cannabis Science
The two protected cultivars, SOT20R07-007 (known as Farm Gas™) and SOT20R07-005 (known as Driftwood Diesel™), were developed at Aurora Coast, Aurora's industry-leading research and development
More news about: Aurora Cannabis Inc.
May 14, 2026, 06:37 ET SANY Heavy Industry Releases 2025 Sustainability Report
across ESG, innovation, low-carbon transition, talent development and social responsibility. In 2025, the company invested approximately US$724 million in R&D and US$39 million in environmental initiatives, while energy-efficient projects generated savings of US$10 million. The company also recorded measurable
More news about: SANY Group
May 14, 2026, 06:04 ET SANY Heavy Industry Releases 2025 Sustainability Report
across ESG, innovation, low-carbon transition, talent development and social responsibility. In 2025, the company invested approximately US$724 million in R&D and US$39 million in environmental initiatives, while energy-efficient projects generated savings of US$10 million. The company also recorded measurable
More news about: SANY Group
May 14, 2026, 06:00 ET Yuchai Introduces Its First High-Pressure, Direct-Injection Pure Ammonia Internal Combustion Engine For Heavy-Duty Commercial Vehicles
solutions we provide, unlocking significant potential for carbon reductions. Building on this momentum, Yuchai will further strengthen its innovative R&D capabilities in ammonia–energy applications, reinforcing our commitment to helping China achieve its 'Dual Carbon' strategic goals."About
More news about: China Yuchai International
May 14, 2026, 06:00 ET Canadian Solar Reports First Quarter 2026 Results and Announces Appointment of Chief Executive Officer
Chairman and Chief Technology Officer. In this new capacity, Dr. Qu will focus on spearheading the Company's technological innovation and long-term R&D strategy.On April 17, 2026, Canadian Solar announced that the Patent Trial and Appeal Board ("PTAB") of the U.S. Patent and Trademark Office ("USPTO")
More news about: Canadian Solar Inc.
May 14, 2026, 05:29 ET "These Are So Tasty, I Look Forward To Having Them Every Day," Top 5 Gundry MD Mighty Reds Reviews 2026
gummies for approximately two years and have found them to stabilize my digestion system. I take one in the morning and the benefit is tangible." - Raymond R. "Love the energy I get from this product. Wish I could eat it all day long like Candy." - Julie H.
More news about: Gundry MD
May 14, 2026, 04:29 ET ScioSense launches UFC23 ultrasonic flow converter for high-precision, ultra-low-power smart metering
the range from 0 to 50°C. This level of precision and stability supports the signal quality needed in high-end water meter designs, including R1000-class measurement requirements. At the same time, the UFC23 is optimized for battery-powered systems, with standby current of typically 0.8µA
More news about: ScioSense
May 14, 2026, 03:27 ET vivo x Sam Kolder: A Cinematic Journey Across the Landscape of South Africa with X300 Ultra
world-class corporation.While bringing together and developing the best local talents to deliver excellence, vivo is supported by a network of R&D centers in Shenzhen, Dongguan, Nanjing, Beijing, Hangzhou, Shanghai, Xi'an and more cities, focusing on the development of state-of-the-art consumer
More news about: vivo
May 14, 2026, 00:40 ET Marktleider in K-beauty-zonnebrandcrèmes Kolmar Korea breidt uit naar zonverzorging voor hoofdhuid en haar
segmenteert, groeit de vraag naar oplossingen voor de bescherming van hoofdhuid en haar snel", aldus een vertegenwoordiger van Kolmar Korea. "Met onze R&D-capaciteiten op het gebied van productontwikkeling, materiaalinnovatie en evaluatie van de doeltreffendheid willen wij een leidende positie innemen in de
More news about: Kolmar Korea
May 14, 2026, 00:27 ET BioQ fait ses débuts au salon in‑cosmetics Global, mettant en avant la force croissante de la Chine en matière d'innovation dans le domaine des ingrédients
salon le plus prestigieux au monde pour ce qui est des ingrédients cosmétiques, l'événement n'accueille que des entreprises ayant des capacités de R&D et de production indépendantes et éprouvées, ce qui place BioQ aux côtés des géants bien établis. Hou Sen, scientifique principal chez BioQ, a présenté
More news about: BioQ
May 13, 2026, 22:09 ET METiS TechBio, the World's First Publicly Listed AI-Powered Drug Delivery Company, Debuts on the Hong Kong Stock Exchange, "The SpaceX of Pharmaceuticals" Ushers in a New Era of Biopharmaceuticals
Founding-Team Level Joining Forces Across Disciplines, with Sustained Heavy Investment in R&D and Talent DevelopmentMETiS TechBio's R&D team is led by its three co-founders. Building upon the Company's R&D centers in Beijing and Hangzhou, the team brings together multidisciplinary expertise
More news about: METiS TechBio
May 13, 2026, 20:00 ET Fosun Pharma and AriBio Sign Exclusive Global Option Agreement for AR1001 for the Treatment of Alzheimer's Disease
including major regions such as the United States, Europe and Japan. Going forward, both parties will leverage Fosun Pharma's established capabilities in R&D, manufacturing, regulatory affairs and commercialization to accelerate the global launch of AR1001."This global partnership with Fosun Pharma
More news about: Fosun Pharma